Suggested Guidelines for Patient Monitoring: Hepatic and Hematologic Toxicity Attributable to Systemic Dermatologic Drugs
Authors:
- Stephen E. WolvertonSWStephen E. Wolverton
- Kathleen RemlingerKRKathleen Remlinger
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Dermatologic Clinics
- Vol. 25 (2) , 195-205
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Role of Metabolism in Drug-Induced Idiosyncratic HepatotoxicityCritical Reviews in Toxicology, 2005
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003
- Methotrexate in psoriasis: Consensus conferenceJournal of the American Academy of Dermatology, 1998
- Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitisJournal of Hepatology, 1997
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 1995
- Molecular Basis of Drug-Induced Immunological Liver InjurySeminars in Liver Disease, 1995
- Autoantibodies against Cytochromes P‐450 in Drug‐Induced Autoimmune HepatitisAnnals of the New York Academy of Sciences, 1993
- Early indicators of prognosis in fulminant hepatic failureGastroenterology, 1989
- Acetaminophen Hepatotoxicity in AlcoholicsAnnals of Internal Medicine, 1986
- Isoniazid-Associated HepatitisAmerican Review of Respiratory Disease, 1972